Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D03MIP
|
|||
| Former ID |
DIB007620
|
|||
| Drug Name |
SPI-256
|
|||
| Synonyms |
HIV protease inhibitors (Resistant-Repellent), Sequoia
Click to Show/Hide
|
|||
| Indication | Human immunodeficiency virus infection [ICD-11: 1C62; ICD-9: 279.3] | Discontinued in Phase 1 | [1] | |
| Company |
Sequoia Pharmaceuticals Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Human immunodeficiency virus Protease (HIV PR) | Target Info | Inhibitor | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800023938) | |||
| REF 2 | Current and Novel Inhibitors of HIV Protease. Viruses. 2009 December; 1(3): 1209-1239. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.